Dyania Health, Inc. raises $5.3M seed to advance their proprietary and physician-built natural language processing technology to drive better outcomes in clinical research.

Dyania Health’s technology de-identifies and derives clinically accurate meaning from unstructured and structured EMR-based patient data to automate manual chart review, a process commonly used in pre-screening patients for clinical trials, researching biomarkers, and running in-silico synthetic studies. Going forward, the company plans on expanding use cases to several areas throughout clinical trials and research.